首页> 外文期刊>Vector borne and zoonotic diseases >Coexistence of Borrelia spp. and Babesia spp. in Ixodes ricinus ticks in Middle Germany.
【24h】

Coexistence of Borrelia spp. and Babesia spp. in Ixodes ricinus ticks in Middle Germany.

机译:鲍氏疏螺旋体共存。和巴贝斯菌属。在德国中部的宜克多斯ric中。

获取原文
获取原文并翻译 | 示例
           

摘要

Altogether, 430 nymphs and 570 adult Ixodes ricinus ticks were collected in 2006 (n = 506) and 2007 (n = 494) from a forest area in Middle Germany (Thuringia). Single ticks were investigated by polymerase chain reaction and restriction fragment length polymorphism or sequencing for Borrelia spp. (ospA gene) and Babesia spp. (18S rRNA gene). Overall, 27.0% (270/1000) were infected with Borrelia species. Out of these, Borrelia garinii was detected most frequently (133/270)-especially, OspA serotype 6 (51/270), followed by Bo. burgdorferi (70/270), Bo. afzelii (42/270), Bo. valaisiana subgroup I (28/270), not typable Borrelia spp. (5/270), Bo. spielmanii (3/270), Bo. valaisiana subgroup II (2/270), and Bo. lusitaniae (1/270). In 1.4% of investigated ticks mixed infections with several Borrelia spp. occurred. Babesia spp.-specific DNA was detected in 5.0% of ticks. Babesia microti was slightly more prevalent (28/50) than Babesia divergens (20/50). Moreover, 5.9% (16/270) of Borrelia spp.-infected ticks were coinfected with Babesia spp. Knowledge on the degree of heterogeneity of Borrelia species and OspA types is prerequisite not only for local risk assessment, but also for diagnostic test and vaccine development.
机译:在2006年(n = 506)和2007年(n = 494),从德国中部(图林根州)的一片森林地区共采集了430羽若虫和570个成年I虱。通过聚合酶链式反应和限制性片段长度多态性或鲍氏疏螺旋体的测序研究了单个s。 (ospA基因)和巴贝虫属。 (18S rRNA基因)。总体而言,27.0%(270/1000)感染了疏螺旋体。在这些细菌中,最常检测到疏螺旋体(133/270),尤其是OspA血清型6(51/270),其次是Bo。伯格多夫里(70/270),Bo。 afzelii(42/270),Bo。瓦莱西亚纳亚组I(28/270),不是典型的疏螺旋体。 (5/270),博。 spielmanii(3/270),博。瓦莱西亚纳亚组II(2/270)和Bo。 lusitaniae(1/270)。在1.4%的已调查tick中,混合感染有几种疏螺旋体。发生了。在5.0%的s中检出了巴氏杆菌属特异性DNA。微小巴比虫(28/50)比分枝巴比虫(20/50)更为普遍。此外,感染了博氏疏螺旋体的tick中有5.9%(16/270)与巴贝斯虫共感染。对博雷利亚属物种和OspA类型异质性程度的了解不仅是局部风险评估的前提,也是诊断测试和疫苗开发的前提。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号